SCHEMBL11148694

SCHEMBL11148694

CCN1C(=O)CSC1=NC(=O)Nc1c(F)cccc1Cl

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.54
▸ LMNA P02545 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ P2RX7 Q99572 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ EGFR P00533 1/20 0.37
▸ KDR P35968 1/20 0.37
▸ HTT P42858 2/20 0.37
▸ MAPT P10636 2/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ TP53 P04637 1/20 0.35
▸ GRM5 P41594 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11143127 0.92 L3MBTL1 (0.59) L3MBTL1LMNAKMT2AALDH1A1SMN1; SMN2
SCHEMBL11150764 0.88 L3MBTL1 (0.55) L3MBTL1LMNAKMT2AALDH1A1SMN1; SMN2
SCHEMBL11148675 0.88 L3MBTL1 (0.52) L3MBTL1LMNAKMT2AP2RX7ALDH1A1
SCHEMBL11146311 0.86 GRM5 (0.42) L3MBTL1KMT2AALDH1A1SMN1; SMN2NPC1
SCHEMBL11151463 0.82 L3MBTL1 (0.48) L3MBTL1LMNAKMT2AALDH1A1SMN1; SMN2
SCHEMBL11146807 0.81 L3MBTL1 (0.47) L3MBTL1LMNAKMT2AALDH1A1SMN1; SMN2
SCHEMBL11146421 0.81 L3MBTL1 (0.45) L3MBTL1LMNAKMT2AP2RX7ALDH1A1
SCHEMBL10993445 0.80 GRM5 (0.45) KMT2AALDH1A1MAPTGRM5
SCHEMBL11148554 0.79 L3MBTL1 (0.46) L3MBTL1LMNAKMT2AALDH1A1EGFR
SCHEMBL11141810 0.78 L3MBTL1 (0.45) L3MBTL1KMT2AALDH1A1SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4402964-A N-Aryl-N'-(3-methyl or ethyl-4-oxothiazolidinylidene)ureas useful for the treatment of epilepsy MCNEILAB, INC. (US) 1983-09-06 — — US disclosed
Send feedback